Consolidated Balance Sheets - USD ($) $ in Millions	Mar. 31, 2023	Dec. 31, 2022
Investments:
Fixed maturity available-for-sale securities, at fair value (amortized cost: 2023 - $111,528; 2022 - $111,707; allowance for credit losses: 2023 - $39; 2022 - $22)	$ 101,936	$ 99,736
Trading securities	3,266	3,498
Equity securities	414	427
Mortgage loans on real estate, net of allowance for credit losses (portion at fair value: 2023 - $490; 2022 - $487)	18,327	18,301
Policy loans	2,383	2,359
Derivative investments	4,005	3,594
Other investments	3,892	3,739
Total investments	134,223	131,654
Cash and invested cash	3,766	3,343
Deferred acquisition costs, value of business acquired and deferred sales inducements	12,277	12,235
Reinsurance recoverables, net of allowance for credit losses	19,309	19,443
Market risk benefit assets	3,445	2,807
Accrued investment income	1,277	1,253
Goodwill	1,144	1,144
Other assets	19,280	18,802
Separate account assets	148,421	143,536
Total assets	343,142	334,217
Liabilities
Policyholder account balances	116,167	114,435
Future contract benefits	39,757	38,826
Market risk benefit liabilities	1,976	2,078
Deferred front-end loads	5,250	5,052
Payables for collateral on investments	6,803	6,712
Short-term debt	500	500
Long-term debt	5,974	5,955
Other liabilities	11,562	12,021
Separate account liabilities	148,421	143,536
Total liabilities	336,410	329,115
Contingencies and Commitments (See Note 13)
Stockholders' Equity
Common stock – 800,000,000 shares authorized; 169,537,759 and 169,220,511 shares issued and outstanding as of March 31, 2023, and December 31, 2022, respectively	4,560	4,544
Retained earnings	4,940	5,924
Accumulated other comprehensive income (loss)	(3,754)	(6,352)
Total stockholders' equity	6,732	5,102
Total liabilities and stockholders' equity	343,142	334,217
Series C Preferred Stock [Member]
Stockholders' Equity
Preferred stock - 10,000,000 shares authorized	493	493
Series D Preferred Stock [Member]
Stockholders' Equity
Preferred stock - 10,000,000 shares authorized	$ 493	$ 493